Studies on EGFR mutants in NSCLC
Nausea and vomiting risk factors
Phase 2 trial of chemotherapy plus gefitinib as first-line treatment for lung adenocarcinoma
Immunotherapy for lung cancer and trial of ramucirumab plus pembrolizumab
What are the benefits of including chemotherapy in the treatment of endometrial cancer?